UniProt ID | PAR6A_HUMAN | |
---|---|---|
UniProt AC | Q9NPB6 | |
Protein Name | Partitioning defective 6 homolog alpha | |
Gene Name | PARD6A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 346 | |
Subcellular Localization | Cytoplasm. Cell membrane. Cell projection, ruffle. Cell junction, tight junction. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Colocali | |
Protein Description | Adapter protein involved in asymmetrical cell division and cell polarization processes. Probably involved in the formation of epithelial tight junctions. Association with PARD3 may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly. The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins. [PubMed: 10873802 Regulates centrosome organization and function. Essential for the centrosomal recruitment of key proteins that control centrosomal microtubule organization] | |
Protein Sequence | MARPQRTPARSPDSIVEVKSKFDAEFRRFALPRASVSGFQEFSRLLRAVHQIPGLDVLLGYTDAHGDLLPLTNDDSLHRALASGPPPLRLLVQKRAEADSSGLAFASNSLQRRKKGLLLRPVAPLRTRPPLLISLPQDFRQVSSVIDVDLLPETHRRVRLHKHGSDRPLGFYIRDGMSVRVAPQGLERVPGIFISRLVRGGLAESTGLLAVSDEILEVNGIEVAGKTLDQVTDMMVANSHNLIVTVKPANQRNNVVRGASGRLTGPPSAGPGPAEPDSDDDSSDLVIENRQPPSSNGLSQGPPCWDLHPGCRHPGTRSSLPSLDDQEQASSGWGSRIRGDGSGFSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | PQRTPARSPDSIVEV CCCCCCCCCCCEEEE | 34.85 | 21815630 | |
14 | Phosphorylation | TPARSPDSIVEVKSK CCCCCCCCEEEEHHH | 31.73 | 24719451 | |
19 | Ubiquitination | PDSIVEVKSKFDAEF CCCEEEEHHHCCHHH | 34.13 | 29967540 | |
37 | Phosphorylation | ALPRASVSGFQEFSR CCCCHHCCCHHHHHH | 31.25 | 24972180 | |
61 | Phosphorylation | GLDVLLGYTDAHGDL CCCCEEEEECCCCCE | 11.04 | 22210691 | |
62 | Phosphorylation | LDVLLGYTDAHGDLL CCCEEEEECCCCCEE | 25.55 | 22210691 | |
100 | Phosphorylation | QKRAEADSSGLAFAS HHHHHHCCCCCHHHC | 33.10 | 21712546 | |
101 | Phosphorylation | KRAEADSSGLAFASN HHHHHCCCCCHHHCH | 38.07 | 21712546 | |
106 (in isoform 2) | Phosphorylation | - | 11.38 | 22210691 | |
107 | Phosphorylation | SSGLAFASNSLQRRK CCCCHHHCHHHHHHH | 22.09 | 25850435 | |
108 (in isoform 2) | Phosphorylation | - | 43.22 | 22210691 | |
109 | Phosphorylation | GLAFASNSLQRRKKG CCHHHCHHHHHHHCC | 24.31 | 21815630 | |
143 | Phosphorylation | PQDFRQVSSVIDVDL CCCHHHHHCCCCHHC | 15.56 | 22210691 | |
144 | Phosphorylation | QDFRQVSSVIDVDLL CCHHHHHCCCCHHCC | 25.00 | 22210691 | |
154 | Phosphorylation | DVDLLPETHRRVRLH CHHCCCCCCCCEEEC | 20.81 | 28348404 | |
165 | Phosphorylation | VRLHKHGSDRPLGFY EEECCCCCCCCCEEE | 30.11 | 20873877 | |
264 | Phosphorylation | RGASGRLTGPPSAGP ECCCCCCCCCCCCCC | 46.40 | 28111955 | |
268 | Phosphorylation | GRLTGPPSAGPGPAE CCCCCCCCCCCCCCC | 49.33 | 28111955 | |
277 | Phosphorylation | GPGPAEPDSDDDSSD CCCCCCCCCCCCCCC | 57.09 | 33259812 | |
278 | Phosphorylation | PGPAEPDSDDDSSDL CCCCCCCCCCCCCCC | 54.37 | 30278072 | |
282 | Phosphorylation | EPDSDDDSSDLVIEN CCCCCCCCCCCEECC | 32.52 | 30278072 | |
283 | Phosphorylation | PDSDDDSSDLVIENR CCCCCCCCCCEECCC | 41.79 | 30576142 | |
318 | Phosphorylation | CRHPGTRSSLPSLDD CCCCCCCCCCCCCCC | 35.74 | 22617229 | |
319 | Phosphorylation | RHPGTRSSLPSLDDQ CCCCCCCCCCCCCCH | 40.80 | 28985074 | |
322 | Phosphorylation | GTRSSLPSLDDQEQA CCCCCCCCCCCHHHH | 50.12 | 23186163 | |
345 | Phosphorylation | RGDGSGFSL------ CCCCCCCCC------ | 36.37 | 27134283 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PAR6A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PAR6A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278, AND MASSSPECTROMETRY. |